A colonoscopy is recommended every decade for people over 45. The screening is used to detect colon cancer. But roughly 40% of eligible Americans don't get a colonoscopy, often because they don't want ...

Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...

What if you didn't have to get a colonoscopy every decade from ages 45 to 75? No, this isn't an excuse to skip screening for colon cancer, which has been proven to save lives. But there are several ...

Regular stool tests already used in NHS care, combined with dietary information, could help identify people with inflammatory bowel disease (IBD) at higher risk of relapse, a major study suggests.

Predictive cancer diagnostics company Rhythm Biosciences has achieved a major milestone with the peer-reviewed validation of ...

March marks the beginning of Colorectal Cancer Awareness Month. At-home stool tests can be an easier way to screen for colorectal cancer than a dreaded colonoscopy. As the rates of the cancer continue ...

Please provide your email address to receive an email when new articles are posted on . The multitarget stool DNA test had a positive predictive value of 31.4% for detecting advanced adenomas.

October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and ...